Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Increased long-term blood pressure (BP) variability is a predictor of chronic kidney disease (CKD) in patients with type 2 diabetes and hypertension, suggests a recent study.
Regardless of the burden of cardiovascular disease (CVD) risk factors, higher fitness improves survival in elderly adults, according to a new study presented at the recently concluded 68th Annual Scientific Session of the American College of Cardiology (ACC 2019).
Watching too much television and skipping breakfast promote cholesterol plaque buildup in the arteries of the heart. On the other hand, hitting the off button on the TV, leaving the couch and eating a high-energy breakfast act protectively against atherosclerosis and offer substantial benefits in terms of heart health, according to data from the Corinthia epidemiological study presented at the American College of Cardiology Annual Scientific Session 2019.
Sleeping for short hours may have unfavourable effects on blood pressure, with a recent study showing that individuals with short sleep duration nightly are at higher risk of hypertension compared with those who get longer hours.
Use of a smartphone app to monitor blood pressure (BP) remotely, get tips on healthful living and connect with a health coach results in a significant decline in BP within 6 weeks among individuals with both type 2 diabetes (T2D) and uncontrolled hypertension, according to a study presented at the American College of Cardiology’s 68th Annual Scientific Session (ACC 2019).
Not many reproductive-aged women have had their lipid levels checked, with more than three-quarters of those attending a postpartum visit not having undergone lipid screening. This underscores peripartum period as an important window of opportunity for screening, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
High-intensity interval training (HIIT) is better than moderate-intensity continuous training at cutting abdominal fat distribution and total body fat and at increasing lean mass, according to a new study presented at the recently concluded American College of Cardiology's 68th Annual Scientific Session.
Special Reports
Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally and its burden is expected to increase due to the rising prevalence of risk factors such as hypertension, diabetes, and dyslipidaemia. In conjunction with the 23rd ASEAN Federation of Cardiology Congress held in Bangkok, Thailand, Menarini organized a lunch symposium and product theatre to discuss the significance of optimal medical therapy (OMT) in the management of stable CAD, with a focus on the role of ranolazine (Ranexa®).
Despite risk factors for cardiovascular disease (CVD) being similar around the world, the burden of CVD is not uniform across nations. Furthermore, CVD-related death in low- to middle-income countries (LMICs) has increased by two-thirds in the last 30 years, and now account for a whopping 80% of global deaths due to CVD.
Poor adherence to statin therapy is leaving many patients with dyslipidaemia at high risk of potentially life-threatening cardiovascular events. Statins are the current standard of care for reducing the risk of cardiovascular disease in these patients and for improving life expectancy, with possible economic benefits for healthcare systems too. However, many patients with dyslipidaemia are not achieving or maintaining treatment targets because they fail to stick to their prescribed statin therapy. An article co-authored by lipidologist Peter Lansberg, and published in Vascular Health and Risk Management, considers this issue and reviews approaches to overcome non-adherence.
At the Abbott-sponsored symposium held during the 9th Malaysian Endocrine and Metabolic Society Annual Congres sat Hilton Kuala Lumpur, Dr Zanariah Hussein shared her insights into the important role of an emerging marker of hypercholesterolaemia, and its relationship with cardiovascular (CV) and diabetic retinopathy (DR) risks.
Through a cardiology webcast co-hosted by Pfizer, the National Heart Association of Malaysia (NHAM), and the American College of Cardiology (ACC), Dr Ong Mei Lin, Dr Aaron D. Kugelmass and Dr Tracy Wang shared their insights into the importance of secondary prevention measures in reducing the burden of atherosclerotic cardiovascular disease (ASCVD).
At the AstraZeneca-sponsored symposium held during the 9th Malaysian Endocrine and Metabolic Society Annual Congress at Hilton Kuala Lumpur, Professor Ronald Ma highlighted the role of a novel combination therapy in reducing HbA1c levels while simultaneously providing cardiovascular (CV) protection to improve patient outcomes.
The FOURIER trial previously demonstrated that adding the proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor evolocumab to background statin therapy lowered LDL-cholesterol (LDL-C) below target levels and significantly reduced the risks of cardiovascular (CV) events in patients with atherosclerotic cardiovascular disease (ASCVD). At the European Society of Cardiology (ESC) Congress 2018 in Munich, Germany, experts reiterated how evolocumab helps lower LDL-C levels and reduces CV events even in patients with various comorbidities.
Conference Reports
Use of a smartphone app to monitor blood pressure (BP) remotely, get tips on healthful living and connect with a health coach results in a significant decline in BP within 6 weeks among individuals with both type 2 diabetes (T2D) and uncontrolled hypertension, according to a study presented at the American College of Cardiology’s 68th Annual Scientific Session (ACC 2019).
Not many reproductive-aged women have had their lipid levels checked, with more than three-quarters of those attending a postpartum visit not having undergone lipid screening. This underscores peripartum period as an important window of opportunity for screening, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
High-intensity interval training (HIIT) is better than moderate-intensity continuous training at cutting abdominal fat distribution and total body fat and at increasing lean mass, according to a new study presented at the recently concluded American College of Cardiology's 68th Annual Scientific Session.
Long-term results of the POET* trial have suggested that patients with left-sided infective endocarditis (IE) could safely switch from conventional intravenous (IV) antibiotics to oral antibiotics, with oral antibiotics associated with a reduced mortality risk.
Extensive coronary artery calcium (CAC ≥1,000) in patients corresponds to a very high-risk phenotype that is associated with mortality outcomes equal to high-risk patients treated for secondary prevention of cardiovascular disease (CVD), reports a study presented at the American College of Cardiology (ACC) Annual Scientific Sessions 2019.
Following a low-carbohydrate diet to shed excess pounds may be bad for the heart, such that individuals consuming low levels of carbohydrates are at increased risk of developing atrial fibrillation, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
In intravenous drug users, hospital admissions for infective endocarditis (IE) appear to be on the rise, with the prevailing treatment approach shifting away from surgical to medical, according to a new study presented at the recently concluded 68th Annual Scientific Session & Expo of the American College of Cardiology (ACC 2019).
Multimedia
